نتائج البحث

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study

• Authors : Matthias Rau; Kirsten Thiele; Niels-Ulrik Korbinian Hartmann

Subjects: SGLT2 inhibitors; Diabetes; Diastolic function

• Source: Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)

تفاصيل العنوان

Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus.

• Authors : Takayuki Kawata¹ ; Masao Daimon¹; Sakiko Miyazaki¹

• Source: Cardiovascular Diabetology. Aug2015, Vol. 14 Issue 1, p1-8. 8p. 1 Diagram, 3 Charts, 3 Graphs.

تفاصيل العنوان

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study.

• Authors : Rau, Matthias; Thiele, Kirsten; Hartmann, Niels-Ulrik Korbinian

Subjects: VASCULAR resistance; TYPE 2 diabetes; EMPAGLIFLOZIN

• Source: Cardiovascular Diabetology; 1/7/2021, Vol. 20 Issue 1, p1-12, 12p

تفاصيل العنوان

The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better.

• Authors : Loria, Francesco¹ (AUTHOR); Mone, Pasquale^2,3,4 (AUTHOR); Rispoli, Antonella⁵ (AUTHOR)

• Source: Cardiovascular Diabetology. 11/22/2024, Vol. 23 Issue 1, p1-14. 14p.

تفاصيل العنوان

Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.

• Authors : Aziz, Faisal^1,2 (AUTHOR); Tripolt, Norbert J.^1,2 (AUTHOR); Pferschy, Peter N.^1,2 (AUTHOR)

• Source: Cardiovascular Diabetology. 4/27/2024, Vol. 23 Issue 1, p1-10. 10p.

تفاصيل العنوان

Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failure.

• Authors : Packer, Milton¹ (AUTHOR)

• Source: Cardiovascular Diabetology. 8/2/2023, Vol. 22 Issue 1, p1-6. 6p.

تفاصيل العنوان

Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy.

• Authors : Yoo-Ri Chung¹; Se-Jun Park²; Ka Young Moon¹

• Source: Cardiovascular Diabetology. 7/6/2017, Vol. 16, p1-8. 8p. 1 Diagram, 6 Charts.

تفاصيل العنوان

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes.

• Authors : Habibi, Javad^1,2; Aroor, Annayya R.^1,2; Sowers, James R.^1,2,3,4

• Source: Cardiovascular Diabetology. 1/13/2017, Vol. 16, p1-15. 15p. 1 Diagram, 2 Charts, 6 Graphs.

تفاصيل العنوان

Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial.

• Authors : Bizino, Maurice B.¹ ; Jazet, Ingrid M.² ; Westenberg, Jos J. M.¹

• Source: Cardiovascular Diabetology. 4/30/2019, Vol. 18 Issue 1, pN.PAG-N.PAG. 1p. 1 Diagram, 3 Charts, 3 Graphs.

تفاصيل العنوان

Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.

• Authors : Ofstad, Anne Pernille¹ ; Gullestad, Lars^2,3; Orvik, Elsa¹

• Source: Cardiovascular Diabetology. 2013, Vol. 12 Issue 1, p1-8. 8p. 1 Diagram, 2 Charts, 1 Graph.

تفاصيل العنوان